ACW 12.4% 7.1¢ actinogen medical limited

Ann: Xanamen Clinical Development & Investor Update, page-3

  1. 449 Posts.
    lightbulb Created with Sketch. 73
    Nice description Rick. I didn't think we would have a partnership as yet either. Why would a Pharma spend their own money on an experiment when they can side on the side lines and wait and see. If all goes good then they can jump on board. Just one little comment annoys me though "End points not met" In brief the company is not concerned by this as other studies in progress will determine correct dosage, the effects of the drug and patient type to issue the drug to. Am I correct in saying this?
 
watchlist Created with Sketch. Add ACW (ASX) to my watchlist
(20min delay)
Last
7.1¢
Change
-0.010(12.4%)
Mkt cap ! $191.5M
Open High Low Value Volume
8.2¢ 8.3¢ 7.0¢ $1.245M 16.59M

Buyers (Bids)

No. Vol. Price($)
1 200000 7.1¢
 

Sellers (Offers)

Price($) Vol. No.
7.5¢ 42360 1
View Market Depth
Last trade - 16.10pm 22/07/2024 (20 minute delay) ?
ACW (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.